RecruitingNot Applicable

KT vs IASTM on Upper Trapezius Myofascial Trigger Points To Compare Effect of KT VS IASTM on Pain Intensity, Pain Pressure Threshold, Cervical Range of Motion and Functional Disability Level.

Egypt50 participantsStarted 2024-08-01

Plain-language summary

This study would answer the following question: Is there a difference in the effects between IASTM and KT on pain intensity level, pain pressure threshold, cervical range of motion (ROM), functional disability level and satisfaction level in subjects with upper trapezius myofascial trigger points? The aims of this study are: 1. To investigate the effect of KT and IASTM on pain intensity level in subjects with upper trapezius myofascial trigger points. 2. To investigate the effects of KT and IASTM on pain pressure threshold in subjects with upper trapezius myofascial trigger points. 3. To investigate the effects of KT and IASTM on cervical range of motion (ROM) in subjects with myofascial trigger points. 4. To investigate the effect of KT and IASTM on functional disability level in subjects with upper trapezius myofascial trigger points. 5. To investigate the effects of KT and IASTM on satisfaction level in subjects with myofascial trigger points.

Who can participate

Age range

19 Years – 23 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- 1) Fifty subjects with age ranged from 18 to 23 years old (Formen et al., 2014). 2\) From both genders with normal BMI ranges between 18.5:24.9 kg/m2. Had MTrPs of unilateral UT muscle (Shamseldeen et al., 2023). Exclusion Criteria: * 1\. History of whiplash injury (Emshi et al., 2021). 2. History of head, neck, cervical spine or shoulder surgery (Emshi., et al 2021) 3. History of cervical radiculopathy (Emshi et al., 2021) 4. Patients with malignancy (Shamseldeen et al., 2023). 5. Cervical spine fractures (Shamseldeen et al., 2023). 6. Myelopathy (Shamseldeen et al., 2023). 7. Having undergone physical therapy within the past three months before the study. 8\. Non - rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection. 9\. Rheumatologic condition as poly-articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases. 10\. Presence of skin diseases (Luz Júnior et al., 2015). 11. Pregnancy (Luz Júnior et al., 2015).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

KT vs IASTM on upper trapezius myofascial trigger points

Timeframe: one month

pain intensity level

Timeframe: change at pain intensity level through 4 weeks

Trial details

NCT IDNCT06899685

SponsorReham Sayed Mesaed

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-01

Contact for this trial

Reham Sayed Mesaed

01091892299 reham.sayed995@gmail.com

View on ClinicalTrials.gov More Myofacial Pain Syndromes trials